{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:45:35Z","timestamp":1794012335907,"version":"4.8.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ebiom.2022.103957","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T23:56:10Z","timestamp":1647906970000},"page":"103957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8089-4352","authenticated-orcid":false,"given":"Tamas","family":"Pongracz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Nouta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista E.","family":"van Meijgaarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Linty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gestur","family":"Vidarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone A.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom H.M.","family":"Ottenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis H.","family":"Hokke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutte J.C.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5242-3257","authenticated-orcid":false,"given":"Sesmu M.","family":"Arbous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna H.E.","family":"Roukens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Wuhrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7798","key":"10.1016\/j.ebiom.2022.103957_bib0001","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new Coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ebiom.2022.103957_bib0002","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2022.103957_bib0003","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M20-3012","article-title":"Prevalence of Asymptomatic SARS-CoV-2 Infection: a narrative review","volume":"173","author":"Oran","year":"2020","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.ebiom.2022.103957_bib0004","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ebiom.2022.103957_bib0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"596","key":"10.1016\/j.ebiom.2022.103957_bib0006","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf8654","article-title":"High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages","volume":"13","author":"Hoepel","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2022.103957_bib0007","unstructured":"Ankerhold J, Giese S, Kolb P, et\u00a0al. Circulating multimeric immune complexes drive immunopathology in COVID-19. bioRxiv 2021. https:\/\/www.biorxiv.org\/content\/10.1101\/2021.06.25.4498 93v4.full?fbclid=IwAR1VJONET9u_NN5giZO2sCt-Xe_hrnWOzy7IVocCmnMI_wwwuoLzBLIWQ_0"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103957_bib0008","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunol Rev"},{"issue":"8","key":"10.1016\/j.ebiom.2022.103957_bib0009","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.bbagen.2015.10.016","article-title":"Mechanisms of disease: the human N-glycome","volume":"1860","author":"Lauc","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ebiom.2022.103957_bib0010","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3389\/fimmu.2017.00877","article-title":"Decoding the human immunoglobulin G-Glycan repertoire reveals a spectrum of Fc-receptor- and complement-mediated-effector activities","volume":"8","author":"Dekkers","year":"2017","journal-title":"Front Immunol"},{"issue":"31","key":"10.1016\/j.ebiom.2022.103957_bib0011","doi-asserted-by":"crossref","first-page":"12669","DOI":"10.1073\/pnas.1108455108","article-title":"Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose","volume":"108","author":"Ferrara","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.ebiom.2022.103957_bib0012","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.4049\/jimmunol.2100399","article-title":"Fc galactosylation promotes hexamerization of human IgG1, leading to enhanced classical complement activation","volume":"207","author":"van Osch","year":"2021","journal-title":"J Immunol"},{"issue":"6532","key":"10.1016\/j.ebiom.2022.103957_bib0013","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8378","article-title":"Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity","volume":"371","author":"Larsen","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103957_bib0014","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41590-020-00828-7","article-title":"Proinflammatory IgG Fc structures in patients with severe COVID-19","volume":"22","author":"Chakraborty","year":"2021","journal-title":"Nat Immunol"},{"issue":"6504","key":"10.1016\/j.ebiom.2022.103957_bib0015","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.abc5902","article-title":"Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability","volume":"369","author":"Brouwer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2022.103957_bib0016","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4939-6493-2_4","article-title":"High-throughput analysis of IgG Fc Glycopeptides by LC-MS","volume":"1503","author":"Falck","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"7","key":"10.1016\/j.ebiom.2022.103957_bib0017","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1021\/acs.jproteome.6b00171","article-title":"LaCyTools: a targeted liquid chromatography-mass spectrometry data processing package for relative quantitation of glycopeptides","volume":"15","author":"Jansen","year":"2016","journal-title":"J Proteome Res"},{"issue":"10","key":"10.1016\/j.ebiom.2022.103957_bib0018","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.010090","article-title":"High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations","volume":"10","author":"Pucic","year":"2011","journal-title":"Mol Cell Proteom"},{"issue":"3","key":"10.1016\/j.ebiom.2022.103957_bib0019","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10719-015-9626-2","article-title":"Human plasma protein N-glycosylation","volume":"33","author":"Clerc","year":"2016","journal-title":"Glycoconj J"},{"issue":"9","key":"10.1016\/j.ebiom.2022.103957_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201205","article-title":"Cross-laboratory evaluation of multiplex bead assays including independent common reference standards for immunological monitoring of observational and interventional human studies","volume":"13","author":"van Meijgaarden","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103957_bib0021","doi-asserted-by":"crossref","first-page":"19893","DOI":"10.1038\/s41598-020-76914-5","article-title":"Detection of SARS-CoV-2 antibodies is insufficient for the diagnosis of active or cured COVID-19","volume":"10","author":"Escribano","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2022.103957_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104663","article-title":"Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the abbott architect","volume":"133","author":"Maine","year":"2020","journal-title":"J Clin Virol"},{"issue":"16","key":"10.1016\/j.ebiom.2022.103957_bib0023","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients with novel Coronavirus disease 2019","volume":"71","author":"Zhao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2022.103957_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104468","article-title":"Evaluation of the EUROIMMUN anti-SARS-CoV-2 ELISA assay for detection of IgA and IgG antibodies","volume":"129","author":"Beavis","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ebiom.2022.103957_bib0025","doi-asserted-by":"crossref","first-page":"m3339","DOI":"10.1136\/bmj.m3339","article-title":"Risk stratification of patients admitted to hospital with Covid-19 using the ISARIC WHO clinical characterisation protocol: development and validation of the 4C mortality score","volume":"370","author":"Knight","year":"2020","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.ebiom.2022.103957_bib0026","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/gerona\/glt190","article-title":"Glycans are a novel biomarker of chronological and biological ages","volume":"69","author":"Kristic","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.ebiom.2022.103957_bib0027","doi-asserted-by":"crossref","DOI":"10.1007\/s10719-022-10044-0","article-title":"Antibody glycosylation in COVID-19","author":"Pongracz","year":"2022","journal-title":"Glycoconj J"},{"issue":"15","key":"10.1016\/j.ebiom.2022.103957_bib0028","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jama.2020.17052","article-title":"Cytokine levels in critically Ill patients with COVID-19 and other conditions","volume":"324","author":"Kox","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ebiom.2022.103957_bib0029","first-page":"372","article-title":"Composition of the immunoglobulin G glycome associates with the severity of COVID-19","volume":"31","author":"Petrovic","year":"2021","journal-title":"Glycobiology"},{"issue":"5","key":"10.1016\/j.ebiom.2022.103957_bib0030","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1172\/JCI65708","article-title":"Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity","volume":"123","author":"Ackerman","year":"2013","journal-title":"J Clin Investig"},{"issue":"6323","key":"10.1016\/j.ebiom.2022.103957_bib0031","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.aai8128","article-title":"IgG antibodies to dengue enhanced for FcgammaRIIIA binding determine disease severity","volume":"355","author":"Wang","year":"2017","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ebiom.2022.103957_bib0032","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/bjh.12965","article-title":"Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn","volume":"166","author":"Kapur","year":"2014","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.ebiom.2022.103957_bib0033","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood-2013-09-527978","article-title":"A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy","volume":"123","author":"Kapur","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103957_bib0034","doi-asserted-by":"crossref","first-page":"8187","DOI":"10.1038\/s41598-017-08654-y","article-title":"Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation","volume":"7","author":"Sonneveld","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2022.103957_bib0035","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/bjh.14438","article-title":"Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn","volume":"176","author":"Sonneveld","year":"2017","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.ebiom.2022.103957_bib0036","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/bjh.14053","article-title":"Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia","volume":"174","author":"Sonneveld","year":"2016","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.103957_bib0037","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00546-18","article-title":"Differences in IgG Fc glycosylation are associated with outcome of pediatric meningococcal sepsis","volume":"9","author":"de Haan","year":"2018","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.ebiom.2022.103957_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134949","article-title":"In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity","volume":"10","author":"Thomann","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ebiom.2022.103957_bib0039","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/infdis\/jiz643","article-title":"Antibody Fc glycosylation discriminates between latent and active tuberculosis","volume":"222","author":"Lu","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2022.103957_bib0040","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fimmu.2017.00646","article-title":"Fc-Galactosylation of human immunoglobulin gamma isotypes improves C1q Binding and enhances complement-dependent cytotoxicity","volume":"8","author":"Peschke","year":"2017","journal-title":"Front Immunol"},{"issue":"7836","key":"10.1016\/j.ebiom.2022.103957_bib0041","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-020-2600-6","article-title":"Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis","volume":"588","author":"Carvelli","year":"2020","journal-title":"Nature"},{"issue":"5787","key":"10.1016\/j.ebiom.2022.103957_bib0042","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"issue":"31","key":"10.1016\/j.ebiom.2022.103957_bib0043","first-page":"E4339","article-title":"Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity","volume":"112","author":"Washburn","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.ebiom.2022.103957_bib0044","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1172\/JCI82695","article-title":"Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity","volume":"125","author":"Quast","year":"2015","journal-title":"J Clin Investig"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422001414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422001414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:18:34Z","timestamp":1762456714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422001414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":44,"alternative-id":["S2352396422001414"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.103957","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.11.18.21266442","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.103957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103957"}}